12,372 trials
Major Depressive Disorder
Primary: Number of Patients With Adverse Events (AEs) — 56; 1; 7 participants
Pulmonary Disease, Chronic Obstructive
Primary: Change From Baseline (BL) in Trough Forced Expiratory Volume in One Second (FEV1) on Day 85 — -0.007; 0.120; 0.145 Liters — p=<0.001
Major Depressive Disorder
Primary: Change From Baseline in MADRS Total Score After 8 Weeks of Treatment — -14.8; -16.2; -16.5; -16.3 units on a scale — p=0.1321
Bone Metastases in Men With Hormone-Refractory Prostate Cancer · Bone Metastases in Subjects With Advanced Breast Cancer · Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma
Primary: Number of Participants Survived — 13; 12 Participants
Neoplasms, Head and Neck
Primary: Disease Free Survival (DFS) — NA; 53.6 Months — p=0.2251
Major Depressive Disorder
Primary: Montgomery-Asberg Depression Rating Scale (MADRS) — -4.60; -10.5 Rating Score
Major Depressive Disorder
Primary: Mean Change in Montgomery-Asberg Depression Rating Scale (MADRS) Total Score — -9.6; -10.5; -7.4 Rating score — p=0.006
Malaria · Malaria Vaccines
Primary: Percentage of Seroprotected Subjects Against Anti-Hepatitis B (HBs) Antigen — 100; 96 Percentage of subjects
Pulmonary Disease, Chronic Obstructive
Primary: Change From Baseline in Exercise Endurance Time Post-dose at Week 12 of Each Treatment Period — 36.7; 63.2; 49.8; 26.7 Seconds — p=0.321
Pulmonary Disease, Chronic Obstructive
Primary: Change From Baseline (BL) in Trough Forced Expiratory Volume in One Second (FEV1) on Day 169 (Week 24) — -0.031; 0.129; 0.093; 0.207 Liters — p=<0.001
Prostate Cancer
Primary: Change From Baseline in Cortical Silent Period (CSP) Will be Determined Using Transcranial Magnetic Stimulation (TMS) of the Motor Cortex. — 0.001; 0.006 seconds
Influenza
Primary: Geometric Mean Titers Against the Influenza Virus Antigens Following Vaccination With Either a Quadrivalent Influenza Vaccine or a Trivalent Influenza Vaccine…
Porphyria Cutanea Tarda
Primary: Number of Participants Showing Reduction or Elimination of Skin Blistering — 0; 8 participants
Pulmonary Disease, Chronic Obstructive
Primary: Change From Baseline (BL) in Trough Forced Expiratory Volume in One Second (FEV1) on Day 169 (Week 24) — 0.121; 0.211; 0.209; 0.121 Liters — p=<0.001
Influenza
Primary: Number of Seroconverted Subjects Against A/Indonesia/5/2005 (H5N1) — 1427; 1; 293; 1 Subjects